2019 International Congress » Physiology and Pathophysiology

Date: Wednesday, September 25, 2019

Time: 1:15pm-2:45pm

Location: Les Muses, Level 3

Meeting: 2019 International Congress

1:15pm-2:45pm: A videographic tool for quantitative assessment of the Glabellar Reflex

A. Braczynski, J. Schulz, S. Leonhardt, C. Hoog Antink (Aachen, Germany)

1:15pm-2:45pm: Alpha-synuclein interacts with BAF complex in nucleus

N. Sugeno, T. Hasegawa, J. Kobayashi, S. Yoshida, M. Ezura, A. Kikuchi, A. Takeda, M. Aoki (Sendai, Japan)

1:15pm-2:45pm: Blood Metagenomics Analyses of Brazilian Parkinson’s Disease Patients: A Clinical Substype Study

G. Poralla, V. Rayol, N. Woldmar, B. Fadel, L. Giacomin, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

1:15pm-2:45pm: Central Insulin Resistance Index is Independent of Peripheral Insulin Resistance in Parkinson’s disease

M. Tagliati, E. Hogg, T. Wu, K. Makwana, H. Maghzi, A. Garland, E. Tan, C. Riera (Los Angeles, CA, USA)

1:15pm-2:45pm: Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)

1:15pm-2:45pm: DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model

J. Follett, J. Fox, E. Gustavsson, M. Farrrer (Vancouver, BC, Canada)

1:15pm-2:45pm: Dopamine substitution increases connectivity between premotor and motor areas in Parkinson’s disease – a DCM-Study

P. Loehrer, V. Seeger, I. Weber, C. Oehrn, H. Dafsari, M. Tittgemeyer, L. Timmermann (Marburg, Germany)

1:15pm-2:45pm: Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias

X. Jin, D. Milakara, K. Schwabe, J. Krauss, M. Alam (Nanjing, China)

1:15pm-2:45pm: Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients

R. Cerroni, D. Pietrucci, M. Conti, V. Unida, A. Farcomeni, M. Pierantozzi, NB. Mercuri, S. Biocca, A. Desideri, A. Stefani (Rome, Italy)

1:15pm-2:45pm: Evaluation of nigral neuronal apoptosis during postnatal development and adulthood of mice strains with differential sensitivity to MPTP

Y. H, V. Dj, C. Sagar, R. Tr, P. Alladi (Bangalore, India)

1:15pm-2:45pm: Experimental model of developing of Parkinson’s disease

M. Tukhtamishev, F. Akhmedova (Tashkent, Uzbekistan)

1:15pm-2:45pm: Extracellular α-synuclein enters dopaminergic neurons by modulating flotillin-1-assisted DAT endocytosis

T. Hasegawa, J. Kobayashi, N. Sugeno, S. Yoshida, T. Akiyama, Y. Miki, M. Fukuda, M. Ezura, A. Kikuchi, T. Baba, A. Takeda, K. Wakabayashi, H. Okano, M. Aoki (Sendai, Japan)

1:15pm-2:45pm: Functional Capacity in patients with Parkinson’s Disease are related to advanced glycation end-products

JEN. Almeida, NAT. Luna, ROD. Iborra, ANG. Alonso, ADR. -Lima (São Paulo, Brazil)

1:15pm-2:45pm: Functional Proteomic Analysis of Leukocytes from Parkinson’s Disease Patients: A Clinical Perspective on Biomarkers Identification

N. Woldmar, B. Fadel, G. Poralla, L. Giacomin, J. Evaristo, F. Nogueira, A. Rosso, L. Pizzatti (Rio de Janeiro, Brazil)

1:15pm-2:45pm: Hypermethylation of PGC-1α in peripheral blood leukocytes of patients with Parkinson’s disease

X. Yang, SQ. Xu, W. Qian, Q. Xiao (Shanghai, China)

1:15pm-2:45pm: Local field potential recordings in the human pallidum using externalized directional DBS leads

L. Johnson, J. Aman, D. Escobar Sanabria, J. Wang, R. Patriat, M. Petrucci, M. Hill, G. Molnar, S. Cooper, L. Schrock, C. Mackinnon, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)

1:15pm-2:45pm: Lymphocyte Senescence in Parkinson’s Disease

M. Jensen, K. Scott, M. Camacho, A. Kouli, R. Wijeyekoon, I. Solim, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)

1:15pm-2:45pm: Maladaptive Nigrovagal Neuronal Plasticity Causes Ascending Alpha-Synucleinopathy in a Novel Environmental Toxin Based Rat Model of Parkinsonism

T. Subramanian, K. Le, S. Hojjatinia, K. Venkiteswaran, M. Subramanian, L. Anselmi, C. Bove, R. Travagli (Hershey, PA, USA)

1:15pm-2:45pm: Microglia as modulators of exosomal alpha-synuclein transmission

Y. Xia, T. Wang, GX. Zhang, JS. Huang, N. Xiong, L. Liu, F. Wan, L. Kou, SJ. Yin, JJ. Hu, YD. Sun, JW. Wu (Wuhan, China)

1:15pm-2:45pm: Mitigation Effects of a Novel Herbal Medicine Hepad, on neurophysiology.

BJ. Park, DH. Kim, JM. Park (Daejeon, Republic of Korea)

1:15pm-2:45pm: Motor compensation in Parkinson’s disease: a multimodal neuroimaging study

N. Villain, N. Pyatigorskaya, S. Lehericy, R. Vallabregue, S. Fernandez-Vidal, MO. Habert, G. Mangone, JC. Corvol, M. Vidailhet, D. Grabli (Paris, France)

1:15pm-2:45pm: Movement and symptom-modulated local field potentials in globus pallidus internus of Parkinson’s disease

J. Aman, L. Johnson, D. Sanabria, J. Wang, M. Hill, S. Cooper, L. Schrock, M. Petrucci, G. Molnar, C. Mackinnon, R. Patriat, N. Harel, M. Park, J. Vitek (Minneapolis, MN, USA)

1:15pm-2:45pm: Neural plasticity based on the change of the glutamate receptors: Repetition of electrical stimulation for the reduction of Parkinsonian symptoms

GT. Kim, N. Nguyen, KS. Kim (Incheon, Republic of Korea)

1:15pm-2:45pm: Parkinson’s Disease Correlates with Reduced Risk of Hypertension

S. Khakimova, KH. Daminova (Tashkent, Uzbekistan)

1:15pm-2:45pm: Parkinsonism alters directed connectivity in the cortico-subthalamo-pallidal circuit

D. Escobar Sanabria, L. Johnson, Y. Yu, J. Zhang, S. Nebeck, Z. Busby, G. Molnar, J. Vitek (Minneapolis, MN, USA)

1:15pm-2:45pm: Pathological role of GBA2 in GBA1-related disorder

E. Nakanishi, N. Uemura, H. Akiyama, M. Kinoshita, H. Yamakado, S. Takeda, Y. Hirabayashi, R. Takahashi (Kyoto, Japan)

1:15pm-2:45pm: Risk of developing the Parkinson’s disease against the background of diabetes mellitus type 2.

F. Akhmedova, M. Tukhtamishev (Tashkent, Uzbekistan)

1:15pm-2:45pm: RNA binding protein mediated regulation of striatal transcriptome in Parkinson’s disease.

K. Irmady, C. Hale, C. Scheckel, J. Fak, R. Darnell (New York, NY, USA)

1:15pm-2:45pm: Skin could be the new peripheral tissue of interest in Parkinson’s disease transcriptomics

A. Planken, P. Taba, S. Kõks, KM. Kasterpalu, L. Kadastik-Eerme, F. Lättekivi, L. Kurvits, E. Reimann (Tartu, Estonia)

1:15pm-2:45pm: Spiral Analysis Evaluates the Effects of Deep Brain Stimulation in Parkinson disease and Essential Tremor

S. Radmard, S. Pullman (New York, NY, USA)

1:15pm-2:45pm: Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)

1:15pm-2:45pm: The Circulatory Levels of Serotonin, Beta endorphin and Dopamine and their relations to Pain Perception in People with Parkinson’s Disease

H. Khalil, N. Al-Yahya, A. Al-Sharman, M. Alqudah, K. El-Salem (Irbid, Jordan)

1:15pm-2:45pm: The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease

G. Brandt, C. Palmisano, J. Brumberg, N. Pozzi, A. Canessa, G. Pezzoli, I. Isaias, J. Volkmann (Würzburg, Germany)

1:15pm-2:45pm: The interaction between iron metabolism and inflammation in Parkinson´s disease: an in vivo and post mortem study

A. Martín-Bastida, B. Tilley, T. Alireza, S. Gentleman, D. Dexter, R. Ward (London, United Kingdom)

1:15pm-2:45pm: The Level of Neuroendocrine Hormones in Parkinson´s Disease and their Potential Role as Biomarkers : A Pilot Study

J. Kauffmann, M. Unger, G. Giebel, D. Grün, K. Faßbender, M. Fousse (Homburg, Germany)

1:15pm-2:45pm: The role of lipid metabolism in mouse models of Parkinson’s disease

M. Trabjerg, D. Andersen, P. Huntjens, K. Mørk, M. Skjønnemand, M. Oklinski, A. Mørkholt, I. Huijbers, C. Pritchard, L. Kroese, J. Nieland (Aalborg, Denmark)

1:15pm-2:45pm: Therapeutic intervention of LRRK2 kinase inhibitors in Vps35 p.D620N Parkinsonism

I. Tatarnikov, J. Follett, J. Fox, M. Farrer (Vancouver, BC, Canada)

1:15pm-2:45pm: Tissue Engineered Nigrostriatal Pathway as an Anatomically-Inspired Test-Bed for Evaluating Axonal Pathophysiology

E. Clark, L. Struzyna, W. Gordian-Velez, I. Chen, J. Duda, D.K. Cullen (Philadelphia, PA, USA)

1:15pm-2:45pm: Translation of a subject-specific stereotaxic platform to a large animal deep brain stimulation research models

F. Paiva, B. Campbell, A. Martin, L. Frizon, A. Maldonado, A. Machado, K. Baker (Cleveland, OH, USA)

1:15pm-2:45pm: Weighting fibroblasts for future diagnostic prospect

G. Prevot, E. Bezard, L. Cognet, B. Dehay, P. Bon (Bordeaux, France)

1:15pm-2:45pm: Widespread distribution and abundant accumulation of alpha-synuclein oligomers in multiple system atrophy brain

H. Sekiya, H. Kowa, H. Koga, M. Takata, W. Satake, N. Futamura, I. Funakawa, K. Jinnai, M. Kanagawa, K. Kobayashi, T. Toda (Kobe, Japan)

« View all sessions from the 2019 International Congress.